CIA Earnings

CIA reported its FY2025Q3 earnings on 2025-11-06, showcasing a revenue of 62.81M against an estimate of 63.46M, resulting in a -1.03% surprise. The EPS was 0, surpassing the expected 0.06 by 0%. The stock experienced a -5.12% price change on the earnings day and a -5.61% change over the next five days, reflecting market reactions to the results.

Following CIA's FY2025Q3 earnings announcement on 2025-11-06, the stock price moved by -5.12% on the day of the release. Over the subsequent five days, it saw a -5.61% change. Historically, CIA's stock price tends to shift by an average of 2.19% in the 10 days leading up to earnings and 8.53% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate CIA's annual revenue to reach 67.89M, while the EPS is projected at 0.08. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between CIA's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, CIA's stock price typically moves by 2.19% in the 10 days before its earnings and 8.53% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of 0.08 and revenue of 67.89M.

The earnings call highlights several operational and financial challenges, including supply chain issues, increased operating costs, and a significant decrease in cash position. Despite a slight increase in the P65 index price, the overall financial performance appears weak, with increased net debt and negative impacts on revenue. The Q&A section reveals uncertainties about future contracts and destocking timelines, further contributing to a negative sentiment. Dividend payments and shareholder return plans provide some positive aspects, but they are insufficient to counterbalance the overall negative outlook.